Studies found that the expression of S100A2 was decreased in early-stage oral cancer cells and recurrent nasopharyngeal cancer [29, 30], however other investigators suggest S100A2 upregulation in HNSCC [31, 32]. The gene discussed is S100A2; the disease is head and neck squamous cell carcinoma.